NCT05520424

Brief Summary

Providing a combination of synergistic dietary supplements, such as vitamins B6, B12, and folate, as well as curcumin, lemon balm, and American ginseng is hypothesized to promote brain health and aid with brain fog, mental clarity, ability to handle stress, mood, focus, and productivity, as well as promote overall well-being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 29, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

April 3, 2024

Status Verified

April 1, 2024

Enrollment Period

5 months

First QC Date

August 26, 2022

Last Update Submit

April 1, 2024

Conditions

Keywords

FocusMemoryAttentionStress

Outcome Measures

Primary Outcomes (2)

  • Perceived changes in mental health symptoms as measured by Questionnaires

    Questionnaires measure perceived changes in mental health symptoms (e.g., anxiety levels, mental clarity) and stress management on a scale of 0 (low levels of mental health symptoms) to 10 (very high levels of mental health symptoms)

    31 days

  • Perceived changes in stress management as measured by Questionnaires

    Questionnaires measure perceived changes in stress management on a scale of 0 (poor ability to manage stress) to 10 (excellent ability to manage stress)

    31 days

Secondary Outcomes (1)

  • Changes in Cognitive Functioning

    31 days

Other Outcomes (1)

  • Changes in plasma/serum biomarkers associated with brain health

    31 days

Study Arms (1)

The Daily Supplement

EXPERIMENTAL

Participants will use test product daily, and complete Biomarker assessments (at 1st dose, Day 7, Day 31), as well as surveys (at 1st dose, Day 7, Day 31), and Cognitive battery Assessments (at 1st dose, Day 7, Day 31).

Dietary Supplement: The Daily Supplement

Interventions

The Daily SupplementDIETARY_SUPPLEMENT

The ingredient list of the product includes the following: 400mg of curcumin (Longvida) 300mg of lemon balm extract (Cyracos) 200mg of American ginseng (Cereboost) 50mg of epigallocatechin gallate derived from green tea Organic oat milk powder Phosphatidylserine (SerinAid) (active) B6 (in the form of P5P) Folate (Quatrefolic) B12 Silica (non-active)

The Daily Supplement

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • In good general health with no major chronic conditions (e.g., diabetes, coronary heart disease, etc.)

You may not qualify if:

  • Females who are pregnant or breastfeeding
  • Anyone currently taking other supplements
  • Anyone with a known allergic reaction
  • Previous head trauma
  • Anyone with chronic diseases such as diabetes, coronary heart disease, or cancer.
  • Any psychological, mental, or neurodevelopmental disorders
  • Consumes nicotine or marijuana in any form
  • Previous or current alcohol addiction
  • Consume more than 10 drinks per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

MeSH Terms

Conditions

Memory Disorders

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Christopher Hill, PhD

    Citruslabs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2022

First Posted

August 29, 2022

Study Start

June 15, 2022

Primary Completion

October 30, 2022

Study Completion

October 30, 2022

Last Updated

April 3, 2024

Record last verified: 2024-04

Locations